Status:
UNKNOWN
Double Sequential External Defibrillation in Patients With Atrial Fibrillation Refractory to DC Cardioversion
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Atrial Fibrillation
Defibrillators
Eligibility:
All Genders
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is a common cardiac arrhythmia that leads to increased risk of heart failure, hospitalization, thromboembolic events, and death. Restoration of normal heart rhythm is performe...
Detailed Description
Patients presenting to the CCU with persistent AF for direct current (DC) cardioversion, who meet the inclusion criteria and fail to revert to normal sinus rhythm after two DC cardioversion attempts w...
Eligibility Criteria
Inclusion
- \- Atrial Fibrillation patients admitted to the CCU for DC cardioversion, and refractory to at least two trials of DC cardioversion
Exclusion
- Patients with Atrial Fibrillation not requiring DC cardioversion
- Patients with Atrial Fibrillation who reverted after a maximum of two trials of DC cardioversion
Key Trial Info
Start Date :
January 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 21 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03827915
Start Date
January 21 2019
End Date
January 21 2024
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon